Triumeq is a fixed-dose combination antiretroviral medication used to treat hiv infection. It contains the integrase inhibitor dolutegravir together with the nucleoside reverse transcriptase inhibitors tenofovir and lamivudine. The drug works by blocking the viral integrase enzyme, preventing the virus from inserting its genetic material into host cell dna. It also inhibits reverse transcriptase, reducing the ability of hiv to replicate its rna genome into dna. Together these actions suppress viral replication, lowering the amount of virus in the bloodstream. By maintaining low viral loads, Triumeq helps preserve immune function and slows disease progression. The medication is taken once daily as a single pill, providing a convenient regimen for patients.

Triumeq is a combination antiretroviral medication used for hiv treatment. It is indicated for the treatment of hiv infection in adults and children. The two active ingredients are abacavir and dolutegravir which belong to different drug classes. Abacavir inhibits the reverse transcriptase enzyme preventing viral replication and dolutegravir blocks the same enzyme at a later stage of the viral life cycle. Together they reduce viral load and help maintain immune function by limiting the ability of hiv to spread within the body. The medication is taken orally and provides a convenient once daily regimen that simplifies long term management of the disease.

Common side effects of Triumeq may include headache. Some people experience nausea or loss of appetite. Insomnia or difficulty sleeping can also occur. Fatigue or general tiredness is reported by users. Skin rashes or rash-like reactions may appear. Diarrhea or abdominal discomfort is sometimes observed. Pancreatitis or elevated liver enzymes are rare but documented. Most reactions are mild and often improve with continued use.

Triumeq may cause headache as a common side effect. Some patients report nausea or mild stomach discomfort. Fatigue or a feeling of low energy is also frequently reported. Insomnia and difficulty sleeping can occur in certain individuals. Dizziness or light-headedness may be experienced by some users. Rarely, skin rash or fever can develop but these are less typical.